Shares outstanding is not known for ADARx Pharmaceuticals, Inc., so ownership cannot be shown as a share of the company.
No 13F manager has reported this stock in the last 8 quarters.
None.
None.
No insider has filed a notice of proposed sale (Form 144) for ADARx Pharmaceuticals, Inc. in the last 12 months.
There are not yet two fiscal years of reported share counts for ADARx Pharmaceuticals, Inc..
No 13F manager reports holding ADRX.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
OA
Orbimed Advisors LLC
5%+ holder
13D · 14.0%
|
14.9M | — | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
Disclosed stake13D · 14.0%
|
||||||
|
OC
Orbimed Capital GP Vii LLC
5%+ holder
13D · 13.4%
|
14.3M | — | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
Disclosed stake13D · 13.4%
|
||||||
9 more holders behind a free account
See every insider and 5%+ holder of ADARx Pharmaceuticals, Inc..
Sign up freeLoading...
